|

Puxitatug Samrotecan Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Puxi-Sam

Pipeline

Phase 3: 1

Top Sponsors

  • AstraZeneca1

Indications

  • Malignant Solid Tumour1
  • Endometrial Cancer1
  • Cancer1

Tucson, Arizona1 trial

Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

Research Site

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.